Skip to main content
OpenTrials
Completed

NCT Number: NCT02382861

Conventional vs Neurally Adjusted Ventilatory Assist in Difficult Weaning From Mechanical Ventilation

The NAVA, by its more physiological aspect and a better adaptation of the patient to the ventilator with a decrease of asynchronies patients-ventilators, could decrease the duration of weaning and so decrease the duration of invasive mechanical ventilation and the morbi-mortality. The objective of this study is to compare the neurally adjusted ventilatory assist versus the usual management of weaning from mechanical ventilation, in term of duration of weaning, at the patients in period of difficult weaning from the invasive mechanical ventilation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Bordeaux Hôpital Pellegrin

Bordeaux, Aquitaine, 33000, France

About this study

  • Background: The NAVA is a new mode of ventilation which works from the continuous recording of the electromyogram of the diaphragm. In theory, the NAVA delivred a proportional and synchronous assistance, to respiratory efforts allowing a more adequate ventilatory support. However, no study estimates the NAVA in the weaning from mechanical ventilation.
  • Purpose: The NAVA, by its more physiological aspect and a better adaptation of the patient to the ventilator with a decrease of asynchronies patients-ventilators, could decrease the duration of weaning and so decrease the duration of invasive mechanical ventilation and the morbi-mortality. The objective of this study is to compare the neurally adjusted ventilatory assist versus the usual management of weaning from mechanical ventilation, in term of duration of weaning, at the patients in period of difficult weaning from the invasive mechanical ventilation.
  • Detailed description: Approximately 20 to 25 % of the patients under mechanical ventilation who have the general criteria of weaning will not pass a first SBT (Spontaneous Breathing Trial). At this moment, the management of the weaning ventilatoire are made with PSV. The NAVA is proportional assistance and depends on the intensity of the electric diaphragmatic signal (Edi). The respiratory effort of the patient is directly detected from the Edi signal. In theory, the NAVA is a proportional and synchronous respiratory.
  • After a first failure of a SBT, patients respecting the inclusion criteria and exlusion criteria described above are then included in the study and randomized in two groups (control group or NAVA group).
  • In the control group, the PSV is decreased of 2cmH2O daily or several times a day to obtain a good clinical and biologic tolerance, with a respiratory frequency between 15 and 30/min and a tidal volume at 6ml/kg.
  • In the NAVA group, the level of NAVA is daily adjusted to obtain Eadimax corresponding to 60 % of Eadimax of the patient during the SBT to obtain a good clinical and biologic tolerance, with a respiratory frequency between 15 and 30/min and a tidal volume at 6ml/kg.
  • Twice a day, the criteria of SBT are looked for. When they are present, a SBT is realized. If it is a success, the patient will be extube. If it is a failure, the patient will be reventilated in PSV or NAVA according to their group. A non-invasive ventilation preventive or of "rescue" can be administered post-extubation according to criteria. The reintubated criteria are also defined.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18 years
  • Under mechanical ventilation > 48 hours
  • A first failure of a SBT
  • Plateau pressure 30cmH2O with tidal volume 8ml / kg
  • SpO2 ≥ in 90 % with a FiO2 ≥ 50 %, or PaO2 / FiO2 > 150mmHg
  • Positive expiratory pressure 8cmH2O
  • No more of one mg/hour of noradrenaline or adrenalin
  • Temperature >36 and <39°C.
  • Stable neurological state (Glasgow scale > 4) without sedation (or very low sedation).
  • Consent, dated and signed by the patient or his representative.

Exclusion criteria

  • Contraindications to the NAVA (recent high digestive suture or oesophageal varices bleeding < 4 days).
  • Pregnant woman.
  • Age <18 years.
  • Tracheotomy.
  • Cardiac arrest with a reserved neurological prognostic.
  • Therapeutic limitation.

Treatment and study plan

Neurally Adjusted Ventilatory Assist

Device

In the NAVA group, the level of NAVA is daily adjusted to obtain Eadimax corresponding to 60 % of Eadimax of the patient during the SBT to obtain a good clinical and biologic tolerance, with a respiratory frequency between 15 and 30/min and a tidal volume at 6ml/kg.

noninvasive pressure support ventilation

Device

In the control group, the PSV is decreased of 2cmH2O daily or several times a day to obtain a good clinical and biologic tolerance, with a respiratory frequency between 15 and 30/min and a tidal volume at 6ml/kg.

Primary outcomes

  1. Duration of weaning from the mechanical invasive ventilation.

    Time frame: 48 hours after the extubation

    This duration is defined by the period between the first failure of the spontaneous breathing trial (SBT) and 48 hours after the extubation.

Secondary outcomes

  1. Duration between the inclusion and the success of the SBT

    Time frame: 28th day

  2. Duration of invasive mechanical ventilation

    Time frame: 28th day

  3. Rate of failure of SBT

    Time frame: 28th day

  4. Rate of success of SBT

    Time frame: 28th day

  5. Rate of ventilator-associated pneumonia

    Time frame: 28th day

  6. Length of intensive care unit stay

    Time frame: 28th day

  7. Duration of hospitalization

    Time frame: 28th day

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Official study title

A Prospective, Randomized and Controlled Study Estimating the Neurally Adjusted Ventilatory Assist (NAVA) Versus the Pressure Support Ventilatory (PSV) in Difficult Weaning From Mechanical Ventilation

Acronym: SENA

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Mar 9, 2015
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.